Infant Respiratory Distress Syndrome - Symptoms, Reasons And Treatment

Written by Medicover Team and Medically Reviewed by Dr Anurag Mahagaonkar , Neonatologists

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Infant respiratory distress syndrome (IRDS) is a breathing condition that affects newborns. It occurs when a baby's lungs are not fully developed, leading to breathing difficulties. The main cause of IRDS is the lack of a substance called surfactant, which helps the lungs expand and contract properly.

This condition can be challenging for babies as they struggle to breathe on their own. Understanding the factors contributing to IRDS can help healthcare providers provide the necessary support and treatment to improve the baby's breathing and overall health.

What Are the Symptoms of Infant Respiratory Distress Syndrome?

Babies may also have trouble feeding, be very tired, or have a weak cry. If your baby shows any of these signs, seek immediate medical attention. Early diagnosis and treatment are crucial for a positive outcome.

Rapid breathing: Your baby may breathe very quickly or struggle to catch their breath, which can be a sign of respiratory distress syndrome.
Flaring nostrils: If you notice your baby's nostrils widening when they breathe, it could indicate they are having difficulty getting enough oxygen.
Grunting sounds: Your baby may make grunting noises while breathing, which may suggest they are working harder to breathe due to respiratory distress.
Bluish skin color: If your baby's skin, especially around the lips and fingertips, appears bluish or dusky, it could mean they are not getting enough oxygen.
Retractions: Visible pulling in of the chest muscles or rib cage with each breath is a sign of increased breathing effort and may indicate significant respiratory distress.

What Causes Infant Respiratory Distress Syndrome?

Infant Respiratory Distress Syndrome occurs when a newborn's lungs do not produce enough surfactant, a substance that prevents the tiny air sacs in the lungs from collapsing during breathing. This condition is most common in premature babies because their lungs are not fully developed at birth.

Common causes include:

Surfactant deficiency
Immature or underdeveloped lungs
Premature birth
Rare genetic disorders affecting surfactant production

When Should You See a Doctor for Infant Respiratory Distress Syndrome?

Seek immediate medical attention from a neonatologist if a newborn develops signs of breathing difficulty after birth.

Rapid or difficult breathing
Grunting with each breath
Bluish skin or lips
Chest retractions
Poor feeding
Unusual sleepiness or weak cry

Early diagnosis and prompt treatment help prevent serious complications and improve the baby's chances of recovery.

Find Neonatologists for Infant Respiratory Distress Syndrome Treatment Near You

How Is Infant Respiratory Distress Syndrome Diagnosed?

Infant respiratory distress syndrome is diagnosed through physical examination, chest X-rays, and blood tests to assess oxygen levels and lung function. Doctors may also perform a blood gas analysis to measure carbon dioxide and oxygen levels accurately.

This helps in determining the severity of the condition and guiding treatment. Early diagnosis is crucial for prompt intervention and improving outcomes for the baby.

Physical Examination: The healthcare provider will assess the baby's breathing pattern, oxygen levels, and overall health to look for signs of respiratory distress syndrome.
Chest X-ray: A chest X-ray can help identify characteristic features such as a "ground glass" appearance in the lungs, indicating the presence of respiratory distress syndrome.
Blood Gas Analysis: This test measures the levels of oxygen and carbon dioxide in the blood, providing valuable information about the baby's respiratory function.
Pulse Oximetry: A non-invasive test that measures oxygen saturation levels in the blood, often used to monitor respiratory distress and the need for supplemental oxygen.
Blood Tests: Blood tests help evaluate the baby's overall health and rule out infections or other conditions that may cause respiratory distress.

How Is Infant Respiratory Distress Syndrome Treated?

Treatment options for infant respiratory distress syndrome include oxygen therapy, mechanical ventilation, surfactant replacement therapy, and medications to help with lung function.

These treatments aim to improve breathing and oxygen levels in babies with the condition. Your baby's healthcare team will tailor the treatment plan to meet their specific needs and monitor their progress closely to ensure the best possible outcome.

Oxygen Therapy: Providing supplemental oxygen is a key treatment for infant respiratory distress syndrome (IRDS) to ensure that the baby's lungs receive enough oxygen to support proper function.
Surfactant Replacement Therapy: Administering surfactant, a substance that helps the lungs stay open and function properly, is often used to treat IRDS in premature infants whose lungs are not producing enough surfactant on their own.
Mechanical Ventilation: In severe cases of IRDS, mechanical ventilation may be necessary to support the baby's breathing by delivering oxygen-rich air into the lungs through a breathing tube.
Continuous Positive Airway Pressure (CPAP): CPAP therapy involves the delivery of a continuous flow of air to help keep the airways and lungs open, improve oxygen levels, reduce breathing effort, and support normal lung function without the need for invasive ventilation in many cases.

Your health is everything - prioritize your well-being today.

Consult Infant Respiratory Distress Syndrome Doctors Today

What Are the Risk Factors for Infant Respiratory Distress Syndrome?

Infant respiratory distress syndrome risk factors include premature birth, maternal diabetes, multiple pregnancies, cesarean section delivery, and male gender. Other factors such as a family history of the condition, maternal obesity, and lack of prenatal care can also increase the risk.

Understanding these factors can help healthcare providers identify at-risk infants and provide timely interventions to improve outcomes.

Premature birth, particularly before 37 weeks gestation, is a significant risk factor for infant respiratory distress syndrome due to underdeveloped lungs.
Maternal diabetes can increase the likelihood of the baby developing respiratory distress syndrome, as high blood sugar levels can affect lung maturation.
Having a sibling with a history of respiratory distress syndrome can predispose an infant to the condition, suggesting a genetic component.
Cesarean section delivery may elevate the risk of respiratory distress syndrome in newborns, as they may not experience the same hormonal changes as during vaginal delivery that assist in lung maturation.
Maternal factors such as smoking during pregnancy or lack of prenatal care can contribute to an increased risk of infant respiratory distress syndrome.

Frequently Asked Questions

1. What are the common signs of infant respiratory distress syndrome?

Rapid breathing, grunting, flaring nostrils, chest retractions, and bluish skin are common signs of infant respiratory distress syndrome.

2. What lifestyle changes should I make to manage infant respiratory distress syndrome effectively?

Avoid smoking, maintain a healthy diet, attend regular prenatal check-ups, and discuss any concerns with your healthcare provider for effective management of infant respiratory.

3. Are there any risks associated with untreated infant respiratory distress syndrome?

Yes, untreated infant respiratory distress syndrome can lead to serious complications like lung damage, brain injury, and even death.

4. How can infant respiratory distress syndrome be treated and controlled?

Treatment includes respiratory support with oxygen therapy and mechanical ventilation. Prevention with antenatal steroids can help reduce risk.

5. Are there any signs that infant respiratory distress syndrome might recur after treatment?

Recurrent breathing difficulties, wheezing, or needing oxygen again could indicate a recurrence of infant respiratory distress syndrome after treatment.